000167359 001__ 167359
000167359 005__ 20240229133538.0
000167359 0247_ $$2doi$$a10.1002/ijc.33502
000167359 0247_ $$2pmid$$apmid:33544875
000167359 0247_ $$2ISSN$$a0020-7136
000167359 0247_ $$2ISSN$$a1097-0215
000167359 0247_ $$2altmetric$$aaltmetric:99564303
000167359 037__ $$aDKFZ-2021-00305
000167359 041__ $$aeng
000167359 082__ $$a610
000167359 1001_ $$0P:(DE-He78)a7fec7d808abe2d2579a48df08c0f0ad$$aGillmann, Clarissa$$b0$$eFirst author$$udkfz
000167359 245__ $$aSolving problems is smart, preventing them is wise: lessons learned from the 2nd International DKFZ Conference on Cancer Prevention.
000167359 260__ $$aBognor Regis$$bWiley-Liss$$c2021
000167359 3367_ $$2DRIVER$$aarticle
000167359 3367_ $$2DataCite$$aOutput Types/Journal article
000167359 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1625043274_23645
000167359 3367_ $$2BibTeX$$aARTICLE
000167359 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000167359 3367_ $$00$$2EndNote$$aJournal Article
000167359 500__ $$a#EA:E040#LA:E220# / 148(12):3086-3096
000167359 520__ $$aThe second international DKFZ Conference on Cancer Prevention (CCP2020) organized by the German Cancer Research Center (DKFZ) was held as a virtual event on September 17-18, 2020. The event gathered experts on cancer prevention from around the world with the aim of generating a stimulating interchange of opinions between clinicians and basic researchers working in the field. The talks and posters of the conference fueled exciting discussions and debates about the state of the art of cancer prevention and provided a comprehensive outlook on the many aspects of the field. The program was divided into three main sessions, illustrating the most recent methodological approaches and interventions in primary, secondary and tertiary prevention, enriched by introductory lectures depicting the most relevant aspects of each session. The key concepts covered in this meeting were risk factors, early detection, improving life after cancer, cancer prevention in Europe and personalized prevention. The importance of the latter was expressly highlighted, many presentations emphasizing that in the era of personalized medicine, prevention also needs to be based on the unique genetic, epigenetic, social and behavioral characteristics of the individual to achieve maximal efficacy. In this article, we summarize the key messages emerging from each section, with particular attention on the most important challenges yet to be met in the field of cancer prevention. This article is protected by copyright. All rights reserved.
000167359 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000167359 588__ $$aDataset connected to CrossRef, PubMed,
000167359 650_7 $$2Other$$a2nd International DKFZ conference on Cancer Prevention
000167359 650_7 $$2Other$$aearly detection
000167359 650_7 $$2Other$$aimproving life after cancer
000167359 650_7 $$2Other$$apersonalized prevention
000167359 650_7 $$2Other$$arisk factors
000167359 7001_ $$0P:(DE-He78)21844e9ac7a71bf96563e305313670e1$$aPajor, Gabor$$b1$$udkfz
000167359 7001_ $$0P:(DE-He78)6e985c345eb4618b127cf0fe1bff1522$$aRamadori, Pierluigi$$b2$$udkfz
000167359 7001_ $$0P:(DE-He78)f84639cbc39bc20ecda8d00e6de97578$$aAlbers, Peter$$b3$$udkfz
000167359 7001_ $$0P:(DE-He78)1b59582b6c05ac4e57aa8b90dd9667f9$$aMons, Ute$$b4$$udkfz
000167359 7001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b5$$udkfz
000167359 7001_ $$0P:(DE-He78)510eeb92149612d86aa3796059342169$$aKentner, Susan$$b6$$udkfz
000167359 7001_ $$0P:(DE-He78)933f7d725ac87378f459623783585a1f$$aBaumann, Michael$$b7$$eLast author$$udkfz
000167359 773__ $$0PERI:(DE-600)1474822-8$$a10.1002/ijc.33502$$gp. ijc.33502$$n12$$p3086-3096$$tInternational journal of cancer$$v148$$x1097-0215$$y2021
000167359 909CO $$ooai:inrepo02.dkfz.de:167359$$pVDB
000167359 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a7fec7d808abe2d2579a48df08c0f0ad$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000167359 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)21844e9ac7a71bf96563e305313670e1$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000167359 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6e985c345eb4618b127cf0fe1bff1522$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000167359 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f84639cbc39bc20ecda8d00e6de97578$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000167359 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1b59582b6c05ac4e57aa8b90dd9667f9$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000167359 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000167359 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)510eeb92149612d86aa3796059342169$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000167359 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)933f7d725ac87378f459623783585a1f$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000167359 9130_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000167359 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000167359 9141_ $$y2021
000167359 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2020-08-32$$wger
000167359 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2020-08-32$$wger
000167359 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J CANCER : 2018$$d2020-08-32
000167359 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-08-32
000167359 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-08-32
000167359 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-08-32
000167359 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2020-08-32
000167359 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-08-32
000167359 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-08-32
000167359 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-08-32
000167359 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-08-32
000167359 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-08-32
000167359 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-08-32
000167359 9201_ $$0I:(DE-He78)E040-20160331$$kE040$$lE040 Med. Physik in der Strahlentherapie$$x0
000167359 9201_ $$0I:(DE-He78)A360-20160331$$kA360$$lKKE Mol. Hämatologie/Onkologie$$x1
000167359 9201_ $$0I:(DE-He78)F180-20160331$$kF180$$lF180 Chronische Entzündung und Krebs$$x2
000167359 9201_ $$0I:(DE-He78)C130-20160331$$kC130$$lPersonalisierte Früherkennung des Prostatakarzinoms$$x3
000167359 9201_ $$0I:(DE-He78)M050-20160331$$kM050$$lM050 Krebsprävention$$x4
000167359 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x5
000167359 9201_ $$0I:(DE-He78)E220-20160331$$kE220$$lE220 Radioonkologie/Radiobiologie$$x6
000167359 980__ $$ajournal
000167359 980__ $$aVDB
000167359 980__ $$aI:(DE-He78)E040-20160331
000167359 980__ $$aI:(DE-He78)A360-20160331
000167359 980__ $$aI:(DE-He78)F180-20160331
000167359 980__ $$aI:(DE-He78)C130-20160331
000167359 980__ $$aI:(DE-He78)M050-20160331
000167359 980__ $$aI:(DE-He78)C110-20160331
000167359 980__ $$aI:(DE-He78)E220-20160331
000167359 980__ $$aUNRESTRICTED